Apolipoprotein E polymorphism, homocysteine serum levels and hippocampal volume in patients with alcoholism: An investigation of a gene-environment interaction

Pharmacogenomics Journal

Volumn 8, Issue 2, 2008, Pages 117-121

  Wilhelm, J ^a   Frieling, H ^a   von Ahsen, N ^b   Hillemacher, T ^a   Kornhuber, J ^a   Bleich, S ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; HOMOCYSTEINE;

ADULT; AGED; ALCOHOLISM; ALLELE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE ENVIRONMENT INTERACTION; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HIPPOCAMPUS; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; VOLUMETRY;

ADULT; ALCOHOLISM; APOLIPOPROTEIN E4; ENVIRONMENT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 41049109822     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500453     Document Type: Article

References (36)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
2. Payami H, Kaye J, Heston LL, Bird TD, Schellenberg GD. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342: 738.
3. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342:697-699.
4. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH et al. Association of apolipoprotein E allele epsilon 4 with late-Onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-1472.
5. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342: 737.
6. Schneider JA; Gearing M, Robbins RS, de l'Aune W, Mirra SS. Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann Neurol 1995; 38: 131-135.
7. Kalman J, Juhasz A, Majtenyi K, Rimanoczy A, Jakab K, Gardian G et al. Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease. Neurobiol Aging 2000; 21: 555-558.
8. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet 1995; 346: 575.
9. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J et al. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999; 52: 244-248.
10. Tang MX, Stem Y, Marder K, Bell K, Gurland B, Lantigua R et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998; 279: 751-755.
11. Sahota A, Yang M, Gao S, Hui SL, Baiyewu O, Gureje O et al. Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent. Ann Neurol 1997; 42: 659-661.
12. Lahiri DK, Sambamurti K, Bennett DA. Apolipoprotein gene and its interaction with the environmentally driven risk factors: Molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiol Aging 2004; 25: 651-660.
13. Osuntokun BO, Sahota A, Ogunniyi AD, Gureje O, Baiyewu O, Adeyinka A et al. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann Neurol 1995; 38 463-465.
14. Sayi JG, Patel NB, Premkumar DR, Adem A, Winblad B, Matuja WB et al. Apolipoprotein E polymorphism in elderly east Africans. East Afr Med J 1997; 74: 668-670.
15. Harper CG, Kril JJ. Neuropathology of alcoholism. Alcohol Alcohol 1990; 25,: 207-216.
16. Kril JJ, Homewood J. Neuronal changes in the cerebral cortex of the rat following alcohol treatment and thiamin deficiency. J Neuropathol Exp Neurol 1993; 52: 586-593.
17. Lovinger DM, White G, Weight FF. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 1989; 243: 1721-1724.
18. Tsai G, Gastfriend DR, Coyle JT. The glutamatergic basis of human alcoholism. Am J Psychiatry 105; 152: 332-340.
19. Bleich S, Wilhelm J, Graesel E, Degner D, Sperling W, Rössner V et al. Apolipoprotein E epsilon 4 is associated with hippocampal volume reduction in females with alcoholism. J Neural Transm 2003; 110 401-411.
20. Bleich S, Bandelow B, Javaheripour K, Müller A, Degner D, Wilhelm J et al. Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism. Neurosci Lett 2003; 335 179-182.
21. Bleich S, Degner D, Wiltfang J, Maler JM, Niedmann P, Cohrs S et al. Elevated homocysteine levels in alcohol withdrawal. Alcohol Alcohol 2000; 35: 351-354.
22. Hultherg B, Berglund M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res 1993; 17: 687-689.
23. Bleich S, Degner D, Bandelow B, von Ahsen N, Rüther E, Komhuber J. Plasma homocysteine is a predictor of alcohol withdrawal seizures. Neuroreport 2000; 11: 2749-2752.
24. Bayerlein K, Hillemacher T, Reulbach U, Mugele B, Sperling W, Komhuber J et al. Alcoholism-associated hyperhomocysteinemia and previous withdrawal seizures. Biol Psychiatry 2005; 57:1590-1593.
25. Wilhelm J, Bayerlein K, Hillemacher T, Ruenbach U, Frieling H, Kromolan B et al. Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with. alcoholism. J Neural Transm 2006; 113: 357-363.
26. Fullerton SM, Clark AC. Weiss KM, Nickerson DA, Taylor SL, Stengard JH et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin ind maintenance of a major human polymorphism. Am J Hum Genet 2000; 67: 881-900.
27. Zekraoui L, Lagarde JP, Raisonnier A, Gerard N, Aouizerate A, Lucotte G. High frequency of the apolipoprotein E*4 allele in African pygmies and most of the African populations in sub-Saharan Africa. Hum Biol 1997. 69: 575-581.
28. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world: Is APOE*4 a 'thrifty' allele? Ann Hum Genet 1999; 63 (Part 4): 301-310.
29. Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY et al. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 1996; 58: 574-584.
30. Anello G, Gueant-Rodriguez RM, Bosco P, Gueant JL, Romano A, Namour B et al. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 2004, 15: 859-861.
31. Wetterling T, Veltrup C, Driessen M, John U. Drinking pattern and alcohol-related medical disorders. Alcohol Alcohol 1999; 34: 330-336.
32. Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. Folate, vitamin B12, homocysteine, and the MTHFR 677C→T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Arch Gen Psychiatry 2003; 60: 618-626.
33. Frieling N, Römer K, Röschke B, Bönsch D, Wilhelm J, Fiszer R et al. Homocysteine plasma levels are elevated in females with anorexia nervosa. J Neural Transm 2005; 112: 979-985.
34. Werbam PR, Price WH, Blandell G. Apolipoprotein E genotyping by onc Sage PCR. Lancet 1991; 337:1158-1159.
35. Ling BL, Dewaele C, Baeyens WR. Application of micro-scale liquid chromatography with fluorescence detection to the determination of thiols. J Chromatogr 1990; 514: 189-198.
36. Agartz I, Momenan R, Rawlings RR, Kerich MJ, Hommer DW. Hippocampal volume in patients with alcohol dependence. Arch Gen Psychiatry 1999; 56: 356-363.